Search
Now showing items 1-4 of 4
The Kilim plot: A tool for visualizing network meta‐analysis results for multiple outcomes
(2020-06)
Network meta‐analysis (NMA) can be used to compare multiple competing treatments for the same disease. In practice, usually a range of outcomes is of interest. As the number of outcomes increases, summarizing results from ...
Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships
(2020-03)
Which treatment is best for me? This question is at the centre of the clinical consultation. And yet, too often, the question is not answerable with available evidence on drugs and devices. The two Lancet Series papers on ...
Informing National Health Service patients about participation in clinical research: A comparison of opt-in and opt-out approaches across the United Kingdom
(2020-11)
Objective:
Recruitment to clinical research in the National Health Service remains challenging. One barrier is accessing patients to discuss research participation. Two general approaches are used in the United Kingdom ...
Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
(2020-10)
Since the early days of the novel coronavirus
outbreak, a record number of studies have been
launched to test several repurposed and new
medicines as potential treatments for covid-19 An
analysis by the news organisation ...